CardioNet Inc. (NASDAQ: BEAT) Upgraded by Citigroup to Hold
Wednesday, May 04, 2022 1:30 PM

Related Stories



Citigroup upgraded CardioNet Inc. (NASDAQ: BEAT) to Hold from Sell citing business improvement following the company's Q1 results. The firm maintains a $6 price target for shares.

Revenue for the first quarter 2011 was $34.0 million, an increase of 6.9 percent compared with $31.8 million in the first quarter 2010. Gross profit for the first quarter 2011 increased to $20.3 million, or 59.8 percent of revenues, compared with $20.1 million, or 63.1 percent of revenues, in the first quarter 2010. 

Shares last traded at $4.43, up 0.23 percent, on Tuesday. GKSR has a 52-week low of $4 and a 52-week high of $10.16. The company has a total market cap of $0.11 billion. The price to earnings ratio of the company is -0.010, and the PEG ratio is -0.010.

CardioNet Inc. provides ambulatory, continuous and real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health in the United States. It focuses on diagnosing and monitoring cardiac arrhythmias or heart rhythm disorders. The company was incorporated in 1994 and is headquartered in Conshohocken, PA.

 

Sponsors

Symbol :

Advertisement

Market news:

More news


Advertisement

    Recent Estimates

AnalystFirm NameSymbolEPS Estimate
XXXXXXXXXX CSCO$0.32
XXXXXXXXXX EOG$0.52
ja teremtipTTG Investments GE$0.28
XXXXXXXXXX LVS$0.44
XXXXXXXXXX ISRG$2.49
XXXXXXXXXX AAPL$5.35
markinsurace guru CINF$0.36
XXXXXXXXXX AAPL$5.35
XXXXXXXXXX ISRG$2.49
JakeXXXXX PKD$0.06